HEADER SIGNALING PROTEIN 09-MAY-14 2MP1 TITLE SOLUTION STRUCTURE OF THE HUMAN CHEMOKINE CCL19 COMPND MOL_ID: 1; COMPND 2 MOLECULE: C-C MOTIF CHEMOKINE 19; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CCL19; COMPND 5 SYNONYM: BETA-CHEMOKINE EXODUS-3, CK BETA-11, EPSTEIN-BARR VIRUS- COMPND 6 INDUCED MOLECULE 1 LIGAND CHEMOKINE, EBI1 LIGAND CHEMOKINE, ELC, COMPND 7 MACROPHAGE INFLAMMATORY PROTEIN 3 BETA, MIP-3-BETA, SMALL-INDUCIBLE COMPND 8 CYTOKINE A19; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CCL19, ELC, MIP3B, SCYA19; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR: PQE30-SMT3 KEYWDS CHEMOKINES, CHEMOKINE RECEPTORS, CCL19, CCL21, CCR7, SIGNALING KEYWDS 2 PROTEIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR C.T.VELDKAMP,F.C.PETERSON,S.J.GABEL-EISSENS,M.L.GILLITZER REVDAT 4 30-OCT-24 2MP1 1 REMARK REVDAT 3 14-JUN-23 2MP1 1 REMARK REVDAT 2 16-SEP-15 2MP1 1 JRNL REVDAT 1 10-JUN-15 2MP1 0 JRNL AUTH C.T.VELDKAMP,E.KIERMAIER,S.J.GABEL-EISSENS,M.L.GILLITZER, JRNL AUTH 2 D.R.LIPPNER,F.A.DISILVIO,C.J.MUELLER,P.L.WANTUCH, JRNL AUTH 3 G.R.CHAFFEE,M.W.FAMIGLIETTI,D.M.ZGOBA,A.A.BAILEY,Y.BAH, JRNL AUTH 4 S.J.ENGEBRETSON,D.R.GRAUPNER,E.R.LACKNER,V.D.LAROSA, JRNL AUTH 5 T.MEDEIROS,M.L.OLSON,A.J.PHILLIPS,H.PYLES,A.M.RICHARD, JRNL AUTH 6 S.J.SCHOELLER,B.TOUZEAU,L.G.WILLIAMS,M.SIXT,F.C.PETERSON JRNL TITL SOLUTION STRUCTURE OF CCL19 AND IDENTIFICATION OF JRNL TITL 2 OVERLAPPING CCR7 AND PSGL-1 BINDING SITES. JRNL REF BIOCHEMISTRY V. 54 4163 2015 JRNL REFN ISSN 0006-2960 JRNL PMID 26115234 JRNL DOI 10.1021/ACS.BIOCHEM.5B00560 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : XPLOR-NIH 2.9.3, CYANA 3.1 REMARK 3 AUTHORS : REMARK 3 SCHWIETERS,C.D.,KUSZEWSKI,J.J.,TJANDRA,N.,CLORE,G.M. (XPLOR-NIH), REMARK 3 GUNTERT, P. (CYANA) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: CCL19 STRUCTURES ARE BASED ON A TOTAL REMARK 3 OF 2481 NOE CONSTRAINTS ( 1559 INTRA, 398 SEQUENTIAL, 171 MEDIUM, REMARK 3 353 LONG RANGE) AND 85 PHI AND PSI DIHEDRAL ANGLE CONSTRAINTS., REMARK 3 CCL19 STRUCTURES ARE BASED ON A TOTAL OF 2481 NOE CONSTRAINTS ( REMARK 3 1559 INTRA, 398 SEQUENTIAL, 171 MEDIUM, 353 LONG RANGE) AND 85 REMARK 3 PHI AND PSI DIHEDRAL ANGLE CONSTRAINTS. REMARK 4 REMARK 4 2MP1 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 12-MAY-14. REMARK 100 THE DEPOSITION ID IS D_1000103879. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 5.6 REMARK 210 IONIC STRENGTH : 6 MM REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : .515 MM [U-100% 13C; U-100% 15N] REMARK 210 HUMAN CHEMOKINE CCL19, 10 % [U- REMARK 210 99% 2H] D2O, 25 MM [U-100% 2H] REMARK 210 DUETERATED MES, 90% H2O, 10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 3D_15N-SEPARATED_NOESY; 3D_13C REMARK 210 -SEPARATED_NOESY; 3D_13C- REMARK 210 SEPARATED_NOESY (AROMATIC) REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : DRX REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : TOPSPIN 3.1, NMRPIPE 2007, XEASY REMARK 210 1.3, GARANT 2.1, CARA 1.8.4 REMARK 210 METHOD USED : AUTOMATED METHODS WERE USED FOR REMARK 210 BACKBONE CHEMICAL SHIFT REMARK 210 ASSIGNMENT AND ITERATIVE NOE REMARK 210 REFINEMENT. FINAL STRUCTURES REMARK 210 WERE OBTAINED BY MOLECULAR REMARK 210 DYNAMICS IN EXPLICIT SOLVENT, REMARK 210 AUTOMATED METHODS WERE USED FOR REMARK 210 BACKBONE CHEMICAL SHIFT REMARK 210 ASSIGNMENT AND ITERATIVE NOE REMARK 210 REFINEMENT. FINAL STRUCTURES REMARK 210 WERE OBTAINED BY MOLECULAR REMARK 210 DYNAMICS IN EXPLICIT SOLVENT REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : TARGET FUNCTION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 ASN A 3 84.11 53.59 REMARK 500 1 LEU A 10 -64.02 -96.28 REMARK 500 1 PRO A 16 -87.92 -46.98 REMARK 500 2 THR A 2 -69.65 -148.80 REMARK 500 2 CYS A 34 148.51 -178.82 REMARK 500 2 MET A 72 103.05 -37.24 REMARK 500 2 ARG A 75 -148.99 -142.04 REMARK 500 3 ASP A 4 -158.25 74.98 REMARK 500 3 GLU A 6 77.61 50.86 REMARK 500 3 PRO A 16 -85.61 -52.99 REMARK 500 3 ARG A 75 93.57 66.79 REMARK 500 4 GLU A 6 -67.50 65.16 REMARK 500 4 ASP A 7 -59.19 -136.33 REMARK 500 4 SER A 11 142.57 -174.38 REMARK 500 4 PRO A 16 -73.03 -44.99 REMARK 500 4 CYS A 34 -176.08 -171.59 REMARK 500 5 ASP A 4 -78.80 43.34 REMARK 500 5 PRO A 16 -164.09 -67.48 REMARK 500 5 ALA A 38 146.26 -170.65 REMARK 500 5 LYS A 71 -91.01 53.05 REMARK 500 5 SER A 76 75.98 61.09 REMARK 500 6 THR A 2 99.05 -69.93 REMARK 500 6 ASN A 3 159.41 70.73 REMARK 500 6 ASP A 4 -46.35 73.75 REMARK 500 6 ASP A 7 70.36 -117.04 REMARK 500 6 CYS A 8 -176.63 178.14 REMARK 500 6 PRO A 16 -80.11 -51.39 REMARK 500 6 CYS A 34 140.85 -173.10 REMARK 500 6 LYS A 73 -82.78 62.80 REMARK 500 6 ARG A 74 -49.05 -137.91 REMARK 500 7 THR A 2 91.86 63.57 REMARK 500 7 ASN A 3 -49.45 -155.01 REMARK 500 7 PRO A 16 -76.12 -49.39 REMARK 500 8 GLU A 6 -8.69 48.74 REMARK 500 8 LEU A 10 -64.86 -92.00 REMARK 500 8 PRO A 16 -73.44 -42.36 REMARK 500 8 ARG A 35 29.25 -72.80 REMARK 500 8 MET A 72 85.10 57.53 REMARK 500 8 ARG A 74 -61.16 74.43 REMARK 500 9 GLU A 6 -161.28 58.16 REMARK 500 9 LYS A 15 100.61 -162.04 REMARK 500 9 PRO A 16 -82.59 -51.52 REMARK 500 9 LYS A 71 -67.81 65.64 REMARK 500 9 ARG A 74 75.84 55.55 REMARK 500 10 ASN A 3 93.06 62.25 REMARK 500 10 SER A 11 -173.97 -177.19 REMARK 500 10 PRO A 16 -86.24 -54.07 REMARK 500 10 MET A 72 -167.26 -126.96 REMARK 500 10 ARG A 75 21.95 -149.88 REMARK 500 10 SER A 76 81.87 69.47 REMARK 500 REMARK 500 THIS ENTRY HAS 89 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 19960 RELATED DB: BMRB DBREF 2MP1 A 1 77 UNP Q99731 CCL19_HUMAN 22 98 SEQRES 1 A 77 GLY THR ASN ASP ALA GLU ASP CYS CYS LEU SER VAL THR SEQRES 2 A 77 GLN LYS PRO ILE PRO GLY TYR ILE VAL ARG ASN PHE HIS SEQRES 3 A 77 TYR LEU LEU ILE LYS ASP GLY CYS ARG VAL PRO ALA VAL SEQRES 4 A 77 VAL PHE THR THR LEU ARG GLY ARG GLN LEU CYS ALA PRO SEQRES 5 A 77 PRO ASP GLN PRO TRP VAL GLU ARG ILE ILE GLN ARG LEU SEQRES 6 A 77 GLN ARG THR SER ALA LYS MET LYS ARG ARG SER SER HELIX 1 1 GLN A 55 ALA A 70 1 16 SHEET 1 A 3 VAL A 22 LEU A 28 0 SHEET 2 A 3 ALA A 38 THR A 43 -1 O THR A 42 N ARG A 23 SHEET 3 A 3 GLN A 48 ALA A 51 -1 O LEU A 49 N PHE A 41 SSBOND 1 CYS A 8 CYS A 34 1555 1555 2.04 SSBOND 2 CYS A 9 CYS A 50 1555 1555 2.00 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1